Hakki Ogün Sercan

475 total citations
22 papers, 364 citations indexed

About

Hakki Ogün Sercan is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Hakki Ogün Sercan has authored 22 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in Hakki Ogün Sercan's work include Cancer-related gene regulation (12 papers), Wnt/β-catenin signaling in development and cancer (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Hakki Ogün Sercan is often cited by papers focused on Cancer-related gene regulation (12 papers), Wnt/β-catenin signaling in development and cancer (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Hakki Ogün Sercan collaborates with scholars based in Türkiye, Sweden and Czechia. Hakki Ogün Sercan's co-authors include Jacomijn P. Dijksterhuis, Karen Stanger, Yun Ji, Gunnar Schulte, Bolormaa Baljinnyam, Rami N. Hannoush, Jeffrey S. Rubin, Ayhan Bılır, Ayşegül Uysal and Gülperi Öktem and has published in prestigious journals such as Journal of Biological Chemistry, Gene and Oncology Reports.

In The Last Decade

Hakki Ogün Sercan

22 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakki Ogün Sercan Türkiye 10 259 97 55 43 37 22 364
Michaël H. Meel Netherlands 13 172 0.7× 68 0.7× 65 1.2× 41 1.0× 52 1.4× 20 367
Julien Deheuninck France 7 343 1.3× 110 1.1× 44 0.8× 50 1.2× 13 0.4× 8 455
Julia Frede United States 6 200 0.8× 100 1.0× 63 1.1× 19 0.4× 19 0.5× 11 283
Milou Tenhagen Netherlands 9 242 0.9× 133 1.4× 67 1.2× 29 0.7× 15 0.4× 9 334
Burkhard Alber Germany 5 214 0.8× 146 1.5× 113 2.1× 14 0.3× 21 0.6× 7 375
Nikki A. Evensen United States 8 212 0.8× 109 1.1× 107 1.9× 34 0.8× 38 1.0× 18 352
Tianhui Zhu China 10 262 1.0× 90 0.9× 132 2.4× 21 0.5× 18 0.5× 14 364
Benjamin T. Goetz United States 9 184 0.7× 73 0.8× 33 0.6× 29 0.7× 61 1.6× 12 300
Hazel T. Salunga United States 4 443 1.7× 56 0.6× 36 0.7× 29 0.7× 44 1.2× 4 537
Xu-Yu Yang United States 13 340 1.3× 122 1.3× 118 2.1× 28 0.7× 12 0.3× 23 434

Countries citing papers authored by Hakki Ogün Sercan

Since Specialization
Citations

This map shows the geographic impact of Hakki Ogün Sercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakki Ogün Sercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakki Ogün Sercan more than expected).

Fields of papers citing papers by Hakki Ogün Sercan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakki Ogün Sercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakki Ogün Sercan. The network helps show where Hakki Ogün Sercan may publish in the future.

Co-authorship network of co-authors of Hakki Ogün Sercan

This figure shows the co-authorship network connecting the top 25 collaborators of Hakki Ogün Sercan. A scholar is included among the top collaborators of Hakki Ogün Sercan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakki Ogün Sercan. Hakki Ogün Sercan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yüce, Zeynep, et al.. (2024). Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line. Medical Oncology. 41(5). 109–109. 2 indexed citations
3.
Sercan, Hakki Ogün, et al.. (2021). The intracellular negative regulator genes of the Wnt signaling in imatinib treatment. Annals of Medical Research. 28(11). 2026–2026. 1 indexed citations
4.
Yüce, Zeynep, et al.. (2020). sFRP1 индуцирует микроРНК, модулирующие сигналы Wnt, в клетках хронического миелоидного лейкоза. Молекулярная биология. 54(4). 626–633. 2 indexed citations
5.
Yüce, Zeynep, et al.. (2020). sFRP1 Expression Induces miRNAs That Modulate Wnt Signaling in Chronic Myeloid Leukemia Cells. Molecular Biology. 54(4). 563–569. 2 indexed citations
6.
Yüce, Zeynep, et al.. (2018). Secreted Wnt antagonists in leukemia: A road yet to be paved. Leukemia Research. 69. 24–30. 5 indexed citations
7.
Yüce, Zeynep, et al.. (2017). Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines. Molecular Biology Reports. 44(5). 391–397. 6 indexed citations
8.
Yüce, Zeynep, et al.. (2017). Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors. Tumor Biology. 39(5). 3726131765–3726131765. 10 indexed citations
9.
Dijksterhuis, Jacomijn P., Bolormaa Baljinnyam, Karen Stanger, et al.. (2015). Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs. Journal of Biological Chemistry. 290(11). 6789–6798. 122 indexed citations
10.
Öktem, Gülperi, Hakki Ogün Sercan, Rüçhan Uslu, et al.. (2014). Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids. Oncology Reports. 32(2). 641–649. 44 indexed citations
11.
Öktem, Gülperi, Ayhan Bılır, Rüçhan Uslu, et al.. (2014). Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells. Oncology Letters. 7(6). 2103–2109. 44 indexed citations
12.
Sercan, Hakki Ogün, et al.. (2010). Expression profile of WNT, FZD and sFRP genes in human hematopoietic cells. Leukemia Research. 34(7). 946–949. 16 indexed citations
13.
Sercan, Hakki Ogün, et al.. (2009). sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leukemia Research. 33(8). 1062–1067. 38 indexed citations
14.
Sercan, Hakki Ogün, et al.. (2009). Beta-Catenin Mutations are not Observed in Chronic Myeloid Leukemia. Tumori Journal. 95(6). 836–839. 9 indexed citations
15.
Sercan, Hakki Ogün, et al.. (2007). Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Oncology Reports. 18(6). 1563–9. 9 indexed citations
16.
Genç, Şermin, Kürşad Genç, Hakki Ogün Sercan, et al.. (2004). Analysis of Cytotoxic Τ Lymphocyte Antigen-4 (CTLA-4) Exon 1 Polymorphism in Patients with Type I Diabetes Mellitus in a Turkish Population. Journal of Pediatric Endocrinology and Metabolism. 17(5). 7 indexed citations
17.
Özer, Erdener, et al.. (2002). Microsatellite instability is not a common feature in medullary breast cancer. The Breast. 11(6). 473–477. 1 indexed citations
18.
Özer, Erdener, et al.. (2002). Microsatellite Instability in Early-onset Breast Cancer. Pathology - Research and Practice. 198(8). 525–530. 19 indexed citations
19.
Sercan, Hakki Ogün, et al.. (2000). Consistent Loss of Heterozygosity at 14q32 in Lymphoid Blast Crisis of Chronic Myeloid Leukemia. Leukemia & lymphoma. 39(3-4). 385–390. 12 indexed citations
20.
Sercan, Hakki Ogün, Kemal Korkmaz, Mehtap Yazıcıoğlu, Meral Sakızlı, & A Büyükgebiz. (1996). Two Brothers with a 7.0 kb Gene Deletion Associated with Isolated Growth Hormone Deficiency Type 1A. Journal of Pediatric Endocrinology and Metabolism. 9(3). 423–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026